x min read

Morning Watch List: Alcatel Lucent SA (ADR) (NYSE:ALU), American International Group, Inc. (NYSE:AIG), DIRECTV (NASDAQ:DTV), Novartis AG (NYSE:NVS), Tompkins Financial Corporation (NYSEMKT:TMP)

Morning Watch List: Alcatel Lucent SA (ADR) (NYSE:ALU), American International Group, Inc. (NYSE:AIG), DIRECTV (NASDAQ:DTV), Novartis AG (NYSE:NVS), Tompkins Financial Corporation (NYSEMKT:TMP)
Written by
Charles Donlon
Published on
November 10, 2014
Copy URL
Share on LinkedIn
Share on Reddit
Share on Twitter/X
Share on Facebook
InsidrFinancial

Zacks restated their neutral rating on shares of Alcatel Lucent SA (NYSE:ALU) in a report released on Friday. Zacks currently has a $3.25 price objective on the stock. Alcatel Lucent SA (ADR) (NYSE:ALU) belongs to Technology sector. Its net profit margin is -3.20% and weekly performance is 10.67%. On last trading day company shares ended up $3.32. Alcatel Lucent SA (ADR) (NYSE:ALU) distance from 50-day simple moving average (SMA50) is 11.32%. American International Group, Inc. (NYSE:AIG), is closing an office in Georgia with 420 workers. American International Group, Inc. (NYSE:AIG) shares moved up 0.22% in last trading session and ended the day at $54.03. AIG return on assets is 1.60%. American International Group, Inc. (NYSE:AIG) quarterly performance is 2.37%. The NFL has been a consistent lure for DIRECTV (NASDAQ:DTV), the only source of the league’s all-access Sunday Ticket package. But a funny thing happened in the past quarter, just as hard-core football fans should have been hearing the siren call of the coming NFL season: DirecTV lost 28,000 subscribers. On 07 November, DIRECTV (NASDAQ:DTV) shares moved down -0.09% and was closed at $87.40. DTV EPS growth in last 5 year was 30.60%. DIRECTV (NASDAQ:DTV) year to date (YTD) performance is 26.56%. Novartis AG (NYSE:NVS) announced that the US Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee or ODAC did not recommend the investigational compound LBH589 or panobinostat, a pan-deacetylase (pan-DAC) inhibitor, for patients with previously treated multiple myeloma when used in combination with bortezomib and dexamethasone. Novartis AG (NYSE:NVS) belongs to Healthcare sector. Its net profit margin is 24.60% and weekly performance is -1.00%. On last trading day company shares ended up $91.76. Novartis AG (NYSE:NVS) distance from 50-day simple moving average (SMA50) is 0.14%.Tompkins Financial (NYSE:TMP) CFO Francis M. Fetsko sold 2,473 shares of the company’s stock on the open market in a transaction dated Thursday, November 6th. The shares were sold at an average price of $49.45, for a total value of $122,289.85. Following the completion of the transaction, the chief financial officer now directly owns 8,367 shares in the company, valued at approximately $413,748. Tompkins Financial Corporation (NYSEMKT:TMP) shares moved down -0.74% in last trading session and ended the day at $49.78. TMP return on assets is 1.10%. Tompkins Financial Corporation (NYSEMKT:TMP) quarterly performance is 11.27%.

Discover Hidden Gems

Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.